November 15th 2024
The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.
Alzheimer’s study sheds light on how DHA absorbed in brains with cognitive decline
August 7th 2020APOE4—a gene variant linked to inflammation in the brain and a known factor for increasing Alzheimer’s disease risk may reduce delivery of DHA and EPA to the brain before the onset of cognitive impairment, requiring higher doses of DHA.
New AI-based system, MedicascyAI, predicts where ingredients will have significant impact
July 28th 2020Medicascy Artificial Intelligence Solutions Platform is a new technology that uses artificial intelligence to predict, in just a few weeks, where ingredients will have significant impact, cutting research and development time while improving the product.
Black seed oil and omega-3 combination supports obesity-related inflammation, says new study
June 26th 2020Thymoquinone, the main bioactive quinone in black seed oil is known to be an antioxidant, and supports inflammation, while omega-3s have been known to support insulin sensitivity and glucose homeostasis in obesity.
Krill oil is significant choline source without spiking trimethylamine n-oxide concentrations
March 4th 2020A study published in Nutrients compared the pharmacokinetics of free choline and of selected choline metabolites from a single dose of phosphatidylcholine present in the branded SuperbaBoost krill oil and choline bitartrate salts.
Best-selling omega-3 supplements comply with regulatory requirements, says GOED study
January 29th 2020GOED tested the quality of 48 of the most-widely sold EPA/DHA omega-3 supplements in the US. Quality was determined by testing the EPA/DHA content of the products, and comparing it labeled content on the bottle.